Nature Communications · 2015 · 135 citations · 63 references
MedicineGeneticsOncologyMolecular OncologyNeoplasiaTumor ProgressionCancer Molecular PathologyCancer ProgressionEpithelial-mesenchymal TransitionOncogene MutationsOncogenic Signaling PathwaysPancreatic CancerAtaxia-telangiectasia Mutated SignalingAtaxia-telangiectasia SignalingAtm DeficiencyEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersFibrotic ChangeOncogenic Driver Mutations
Pancreatic ductal adenocarcinoma (PDAC) is associated with accumulation of particular oncogenic mutations and recent genetic sequencing studies have identified ataxia telangiectasia-mutated (ATM) mutations in PDAC cohorts. Here we report that conditional deletion of ATM in a mouse model of PDAC induces a greater number of proliferative precursor lesions coupled with a pronounced fibrotic reaction. ATM-targeted mice display altered TGFβ-superfamily signalling and enhanced epithelial-to-mesenchymal transition (EMT) coupled with shortened survival. Notably, our mouse model recapitulates many features of more aggressive human PDAC subtypes. Particularly, we report that low expression of ATM predicts EMT, a gene signature specific for Bmp4 signalling and poor prognosis in human PDAC. Our data suggest an intimate link between ATM expression and pancreatic cancer progression in mice and men.
63
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Trastuzumab-Induced Hepatotoxicity: A Case Report
D. Vucicevic, Elizabeth J. Carey, Nina J. Karlin · Breast Care · 2013 · 4.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Siân Jones, D. Williams Parsons, Jimmy Lin et al. · Science · 2008 · 4K citations · Full text
Pepijn Brocken, P.N.R. Dekhuijzen, Liesbeth Peters-Bax et al. · Respiration · 2013 · 4K citations · Full text